Matthew J Crowley1,2, David Edelman1,3, Ann T McAndrew4, Susan Kistler4, Susanne Danus1, Jason A Webb3,5,6, Joseph Zanga3,5,6, Linda L Sanders3, Cynthia J Coffman1,7, George L Jackson1,3, Hayden B Bosworth1,3. 1. 1 Center for Health Services Research in Primary Care, Durham Veterans Affairs Medical Center , Durham, North Carolina. 2. 2 Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Duke University , Durham, North Carolina. 3. 3 Division of General Internal Medicine, Department of Medicine, Duke University , Durham, North Carolina. 4. 4 Home Telehealth Program, Durham Veterans Affairs Medical Center , Durham, North Carolina. 5. 5 Department of Psychiatry and Behavioral Medicine, Duke University , Durham, North Carolina. 6. 6 Mental Health Service, Durham Veterans Affairs Medical Center , Durham, North Carolina. 7. 7 Department of Biostatistics and Bioinformatics, Duke University Medical Center , Durham, North Carolina.
Abstract
BACKGROUND:Telemedicine-based diabetes management improves outcomes versus clinic care but is seldom implemented by healthcare systems. In order to advance telemedicine-based management as a practical option for veterans with persistent poorly controlled diabetes mellitus (PPDM) despite clinic-based care, we evaluated a comprehensive telemedicine intervention that we specifically designed for delivery using existing Veterans Health Administration (VHA) clinical staffing and equipment. MATERIALS AND METHODS: We conducted a 6-month randomized trial among 50 veterans with PPDM; all maintained hemoglobinA1c (HbA1c) levels continuously >9.0% for >1 year despite clinic-based management. Participants received usual care or a telemedicine intervention combining telemonitoring, medication management, self-management support, and depression management; existing VHA clinical staff delivered the intervention. Using linear mixed models, we examined HbA1c, diabetes self-care (measured by the Self-Care Inventory-Revised questionnaire), depression, and blood pressure. RESULTS: At baseline, the model-estimated common HbA1c intercept was 10.5%. By 6 months, estimated HbA1c had improved by 1.3% for intervention participants and 0.3% for usual care (estimated difference, -1.0%, 95% confidence interval [CI], -2.0%, 0.0%; p = 0.050). Intervention participants' diabetes self-care (estimated difference, 7.0; 95% CI, 0.1, 14.0; p = 0.047), systolic blood pressure (-7.7 mm Hg; 95% CI, -14.8, -0.6; p = 0.035), and diastolic blood pressure (-5.6 mm Hg; 95% CI, -9.9, -1.2; p = 0.013) were improved versus usual care by 6 months. Depressive symptoms were similar between groups. CONCLUSIONS: A comprehensive telemedicine intervention improved outcomes among veterans with PPDM despite clinic-based care. Because we specifically designed this intervention with scalability in mind, it may represent a practical, real-world strategy to reduce the burden of poor diabetes control among veterans.
RCT Entities:
BACKGROUND: Telemedicine-based diabetes management improves outcomes versus clinic care but is seldom implemented by healthcare systems. In order to advance telemedicine-based management as a practical option for veterans with persistent poorly controlled diabetes mellitus (PPDM) despite clinic-based care, we evaluated a comprehensive telemedicine intervention that we specifically designed for delivery using existing Veterans Health Administration (VHA) clinical staffing and equipment. MATERIALS AND METHODS: We conducted a 6-month randomized trial among 50 veterans with PPDM; all maintained hemoglobin A1c (HbA1c) levels continuously >9.0% for >1 year despite clinic-based management. Participants received usual care or a telemedicine intervention combining telemonitoring, medication management, self-management support, and depression management; existing VHA clinical staff delivered the intervention. Using linear mixed models, we examined HbA1c, diabetes self-care (measured by the Self-Care Inventory-Revised questionnaire), depression, and blood pressure. RESULTS: At baseline, the model-estimated common HbA1c intercept was 10.5%. By 6 months, estimated HbA1c had improved by 1.3% for intervention participants and 0.3% for usual care (estimated difference, -1.0%, 95% confidence interval [CI], -2.0%, 0.0%; p = 0.050). Intervention participants' diabetes self-care (estimated difference, 7.0; 95% CI, 0.1, 14.0; p = 0.047), systolic blood pressure (-7.7 mm Hg; 95% CI, -14.8, -0.6; p = 0.035), and diastolic blood pressure (-5.6 mm Hg; 95% CI, -9.9, -1.2; p = 0.013) were improved versus usual care by 6 months. Depressive symptoms were similar between groups. CONCLUSIONS: A comprehensive telemedicine intervention improved outcomes among veterans with PPDM despite clinic-based care. Because we specifically designed this intervention with scalability in mind, it may represent a practical, real-world strategy to reduce the burden of poor diabetes control among veterans.
Entities:
Keywords:
e-health; home health monitoring; telehealth; telemedicine
Authors: Allison A Lewinski; Connor Drake; Ryan J Shaw; George L Jackson; Hayden B Bosworth; Megan Oakes; Sarah Gonzales; Nicole E Jelesoff; Matthew J Crowley Journal: J Am Med Inform Assoc Date: 2019-07-01 Impact factor: 4.497
Authors: Allison A Lewinski; Caitlin Sullivan; Kelli D Allen; Matthew J Crowley; Jennifer M Gierisch; Karen M Goldstein; Kaileigh Gray; Susan N Hastings; George L Jackson; Felicia McCant; Abigail Shapiro; Matthew Tucker; Carolyn Turvey; Leah L Zullig; Hayden B Bosworth Journal: J Gen Intern Med Date: 2021-01-26 Impact factor: 6.473
Authors: Sara M Andrews; Nina R Sperber; Jennifer M Gierisch; Susanne Danus; Stephanie L Macy; Hayden B Bosworth; David Edelman; Matthew J Crowley Journal: Patient Prefer Adherence Date: 2017-03-03 Impact factor: 2.711
Authors: Anastasia-Stefania Alexopoulos; George L Jackson; David Edelman; Valerie A Smith; Theodore S Z Berkowitz; Sandra L Woolson; Hayden B Bosworth; Matthew J Crowley Journal: PLoS One Date: 2019-03-29 Impact factor: 3.240
Authors: Patricia Rodríguez-Fortúnez; Josep Franch-Nadal; José A Fornos-Pérez; Fernando Martínez-Martínez; Hector David de Paz; María Luisa Orera-Peña Journal: BMJ Open Date: 2019-06-22 Impact factor: 2.692
Authors: Yilin Yoshida; Suzanne A Boren; Jesus Soares; Mihail Popescu; Stephen D Nielson; Eduardo J Simoes Journal: Curr Diab Rep Date: 2018-10-18 Impact factor: 4.810